Work

BPS2025 - The first GIP/GLP-1 dual agonist, tirzepatide, in high-fat diet- and L-NAME-induced heart failure with preserved ejection fraction (HFpEF) in a mouse model

Year: 2025

Type: conference-abstract

Source: Biophysical Journal

DOI: 10.1016/j.bpj.2024.11.3196

Authors: Jeong Eun Park, Phung N. Thai, Lu Ren, Gauruv Sarode, Daphne A. Diloretto, Zubayer Ibne Ferdous, Ning Zong, Avni Duda, Yu Jia Dong, Chaitali Khadilkar, Prisha Pandita, Nipavan Chiamvimonvat, Padmini Sirish

Institutions: University of California, Davis, Stanford Cardiovascular Institute, University of Arizona

Language: English

Topic: Heart Failure Treatment and Management

Subfield: Cardiology and Cardiovascular Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W4407492244

Cites:

Cited by: 1

Related to: 10